Stockscreener 앱 받기
84.09
2.24%
-1.93
시간 외 거래:
83.89
-0.20
-0.24%
전일 마감가:
$86.02
열려 있는:
$86.02
하루 거래량:
3.57M
Relative Volume:
0.80
시가총액:
$49.37B
수익:
$5.88B
순이익/손실:
$1.34B
주가수익비율:
35.80
EPS:
2.3489
순현금흐름:
$799.60M
1주 성능:
-2.35%
1개월 성능:
+11.69%
6개월 성능:
+8.04%
1년 성능:
+20.92%
1일 변동 폭
$84.02
$86.86
1주일 범위
$83.32
$86.86
52주 변동 폭
$65.94
$87.20
에드워즈라이프사이언시스 Stock (EW) Company Profile
명칭
Edwards Lifesciences Corp
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA
EW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
84.09 | 49.92B | 5.88B | 1.34B | 799.60M | 2.3489 |
|
ABT
Abbott Laboratories
|
123.97 | 219.36B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.60 | 143.81B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
360.48 | 139.29B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.35 | 128.70B | 34.76B | 4.79B | 5.30B | 3.7049 |
에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-10-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-10-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-29 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-04-24 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Stifel | Hold → Buy |
| 2025-01-16 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-11 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-09-18 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-07-31 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-07-25 | 다운그레이드 | Truist | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-03-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-02-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-28 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | 다운그레이드 | Bernstein | Outperform → Underperform |
| 2023-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 개시 | Mizuho | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-27 | 재확인 | Citigroup | Buy |
| 2022-01-27 | 재확인 | Evercore ISI | Outperform |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | Stifel | Buy |
| 2022-01-27 | 재확인 | UBS | Neutral |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-30 | 재확인 | Deutsche Bank | Hold |
| 2021-07-30 | 재확인 | Jefferies | Buy |
| 2021-07-30 | 재확인 | Morgan Stanley | Overweight |
| 2021-07-30 | 재확인 | Oppenheimer | Outperform |
| 2021-07-30 | 재확인 | Stifel | Buy |
| 2021-07-30 | 재확인 | UBS | Neutral |
| 2021-07-30 | 재확인 | Wells Fargo | Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-04-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-11 | 재확인 | Canaccord Genuity | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Underperform |
| 2020-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Outperform |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 재확인 | Canaccord Genuity | Buy |
| 2019-09-23 | 개시 | Piper Jaffray | Overweight |
| 2019-07-24 | 재확인 | BofA/Merrill | Buy |
| 2019-03-18 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Hold |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-10-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
모두보기
에드워즈라이프사이언시스 주식(EW)의 최신 뉴스
Vanguard Group Inc. Grows Position in Edwards Lifesciences Corporation $EW - MarketBeat
Will Edwards Lifesciences Corporation (EWL) stock rise with strong economyJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
Primecap Management Co. CA Acquires 1,147,291 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Highview Capital Management LLC DE Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Stock Holdings Cut by Intech Investment Management LLC - MarketBeat
Why Edwards Lifesciences Corporation stock remains a top recommendationJuly 2025 Outlook & Daily Momentum Trading Reports - newser.com
Tick level data insight on Edwards Lifesciences Corporation volatilityTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Is Edwards Lifesciences Corporation (EWL) stock a top dividend aristocrat candidateQuarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
Why Edwards Lifesciences Corporation stock attracts HNW investors2025 Risk Factors & Safe Capital Allocation Plans - newser.com
Is Edwards Lifesciences Corporation (EWL) stock positioned for secular growthMarket Trend Review & Free Daily Entry Point Trade Alerts - newser.com
What is the fair value estimate for Edwards Lifesciences Corporation (EWL) stock in 2025Market Rally & Weekly High Return Opportunities - newser.com
Can Edwards Lifesciences Corporation (EWL) stock sustain free cash flowPortfolio Update Report & Growth Oriented Trade Recommendations - newser.com
Why Edwards Lifesciences Corporation (EWL) stock stays on top picksPortfolio Risk Summary & Short-Term Swing Trade Alerts - newser.com
Philips, Edwards team on AI-based guide for mitral valve repair - MedTech Dive
What does recent volatility data suggest for Edwards Lifesciences CorporationPortfolio Return Report & Safe Entry Zone Identification - newser.com
Edwards Lifesciences stock rating reiterated at Overweight by Piper Sandler - Investing.com India
How Edwards Lifesciences Corporation stock trades after rate cutsJobs Report & AI Forecast Swing Trade Picks - newser.com
Edwards Lifesciences Corporation $EW Shares Sold by Thoroughbred Financial Services LLC - MarketBeat
Edwards Lifesciences Corporation $EW Shares Acquired by Citigroup Inc. - MarketBeat
What consensus target says about Edwards Lifesciences Corporation stockMarket Sentiment Report & AI Forecast Swing Trade Picks - newser.com
Is Edwards Lifesciences Corporation (EWL) stock a safe buy pre earnings - newser.com
Published on: 2025-11-17 10:29:32 - newser.com
Why Edwards Lifesciences Corporation (EWL) stock stays resilient2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Ontario Teachers Pension Plan Board Raises Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Is Edwards Lifesciences Corporation stock trading at attractive multiplesPortfolio Value Report & Risk Controlled Daily Trade Plans - newser.com
Edwards Lifesciences’ PROGRESS Trial: A Game-Changer in Aortic Stenosis Treatment? - MSN
Edwards Lifesciences’s SWOT analysis: strong TAVR growth drives stock outlook - Investing.com
Published on: 2025-11-17 11:56:48 - newser.com
Edwards Lifesciences Corporation $EW Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $11.25 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Creative Planning Buys 15,336 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation stock trend forecastPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
WealthShield Partners LLC Buys New Position in Edwards Lifesciences Corporation $EW - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Boosts Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Empower Advisory Group LLC Has $74.29 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 48,589 Edwards Lifesciences Corporation $EW - MarketBeat
Using data models to predict Edwards Lifesciences Corporation stock movement2025 Momentum Check & Fast Gain Stock Tips - newser.com
Will Edwards Lifesciences Corporation (EWL) stock test record highs in 2025Wall Street Watch & Capital Efficient Trade Techniques - newser.com
Oak Harvest Investment Services Makes New $2.24 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Impax Asset Management Group plc Acquires 5,106 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
PNC Financial Services Group Inc. Sells 14,592 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Geode Capital Management LLC Buys 45,555 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
에드워즈라이프사이언시스 (EW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.37%
1.29%
자본화:
|
볼륨(24시간):